Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Glavni avtor: | Tanisha, Mehrin Haque |
---|---|
Drugi avtorji: | Kabir, Eva Rahman |
Format: | Thesis |
Jezik: | English |
Izdano: |
Brac University
2021
|
Teme: | |
Online dostop: | http://hdl.handle.net/10361/15533 |
Podobne knjige/članki
-
CAR-T cell Therapy in B-cell Lymphoma
od: Faruk, Asef
Izdano: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Izdano: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Izdano: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
od: Moya, Amena Khatun
Izdano: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
od: Tania, Umme
Izdano: (2021)